---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-003528"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2023-02-03T23:59:59+00:00"
generated_at: "2026-06-20T01:07:43.523597+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Oncocyte extends outside date for Razor Genomics sale to Feb 15, 2023

## Summary
- First Amendment extends closing deadline from Feb 1 to Feb 15, 2023 for sale of 70% of Razor Genomics to Dragon Scientific.
- Oncocyte will retain 30% equity interest in Razor after closing.
- No other terms of the original Stock Purchase Agreement were amended.

## SEC filing metadata
- accession: 0001493152-23-003528
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2023-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000149315223003528/0001493152-23-003528-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000149315223003528/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-003528
- JSON: https://secwatch.observer/filing/0001493152-23-003528.json
- Plain text: https://secwatch.observer/filing/0001493152-23-003528.txt

## Key facts
- Material Agreements
  Insight Molecular Diagnostics Inc. amended First Amendment to Stock Purchase Agreement with Dragon Scientific, LLC valued at Extended the Outside Date from February 1, 2023 to February 15, 2023 (effective 2023-01-30).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: Dragon Scientific, LLC
  - Value: Extended the Outside Date from February 1, 2023 to February 15, 2023
  - Effective: 2023-01-30
  source text: On January 30, 2023, the Company, Buyer and Razor entered into a First Amendment to Stock Purchase Agreement whereby the parties agreed to the extend the Outside Date, as set forth in Section 3.1(e) of the Agreement, to February 15, 2023 (“First Amendment”). No other provisions of the Agreement were otherwise amended or waived by the First Amendment, and the Agreement remains in full force and effect.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642380/000149315223003528/0001493152-23-003528-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.